Antihypertensive therapy: risk stratification in diabetes and cardiac diseases
Baumgart, P.
MMW Fortschritte der Medizin 148(11): 57; 59-60
2006
ISSN/ISBN: 1438-3276 PMID: 16612966 Document Number: 601783
Document emailed within 1 workday
Related Documents
Ravkilde, J. 2000: Risk stratification in acute coronary syndrome using cardiac troponin i Clinical Chemistry 46(4): 443-444Liew, R.; Chiam, P.T.L. 2010: Risk stratification for sudden cardiac death after acute myocardial infarction Annals of the Academy of Medicine Singapore 39(3): 237-246
Chen Yi Ni 2001: Cardiac Troponin I: A Biomarker for Detection and Risk Stratification of Minor Myocardial Damage Clinical Laboratory 47(9-10): 483-492
Saeed, M.; Homoud, M.K.; Wang, P.J.; Estes, N.A.; Link, M.S. 2001: Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death Journal of Invasive Cardiology 13(11): 758-762
Hostetter, T.H. 1989: Antihypertensive therapy in diabetes American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 13(6 Suppl 1: 13-16
Verdecchia, P. 1986: Cardiac protection and antihypertensive therapy: facts and theories Minerva Medica 77(26): 1259-1270
Statsenko, M.E.; Derevyanchenko, M.V. 2015: Cardio-Nephroprotection--the Most Important Goal of Antihypertensive Therapy in Patients with Type 2 Diabetes Kardiologiia 55(8): 43-48
Fomin, V.V. 2012: Fixed dose combinations of antihypertensive drugs and management of risk of development nephropathy in type 2 diabetes mellitus Kardiologiia 52(10): 81-85
Statsenko, M.E.; Derevianchenko, M.V.; Ostrovskiĭ, O.V.; Titarenko, M.N.; Shvets, M.K.; Bondarev, A.M. 2013: Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus Terapevticheskii Arkhiv 85(9): 63-68
Statsenko, M.E.; Derevianchenko, M.V. 2014: Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy Terapevticheskii Arkhiv 86(8): 90-93
Biran, N.; Jagannath, S.; Chari, A. 2013: Risk stratification in multiple myeloma, part 1: characterization of high-risk disease Clinical Advances in Hematology and Oncology: H&o 11(8): 489-503
Levey, R.I.; Leren, P. 1986: Selection of initial antihypertensive therapy: new perspectives on coronary heart disease. Risk factors provide new insights. Introduction American Journal of Medicine 80(2a): 1-2
Winther, K.; Gleerup, G.; Hedner, T. 1992: Enhanced risk of thromboembolic disease in hypertension from platelet hyperfunction and decreased fibrinolytic activity: has antihypertensive therapy any influence? Journal of Cardiovascular Pharmacology 19(Suppl 3): S21-S24
Topol, E. 1998: Patient stratification and its predictive value for cardiac events European Heart Journal 19 Suppl K: K5-K7
Mamedov, M.N.; Perova, N.V.; Kosmatova, O.V.; Khadipash, L.A.; Kiseleva, N.V.; Oganov, R.G. 2003: Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome Kardiologiia 43(3): 13-19
Hintikka, J.; Niskanen, L. 2005: Schizophrenia increases risk of diabetes and cardiovascular diseases Duodecim; Laaketieteellinen Aikakauskirja 121(7): 705-707
Aupetit, J.F.; Brion, R.; Carre, F. 2006: Screening for high risk cardiac diseases in athletes Archives des Maladies du Coeur et des Vaisseaux 99(11): 1111-1114
Kario, K.; Pickering, T.G. 2000: Does extreme dipping of nocturnal blood pressure in elderly hypertensive patients confer high risk of developing ischemic target organ damage from antihypertensive therapy? Archives of Internal Medicine 160(9): 1378
Chertow, G.M.; Lazarus, J.M.; Christiansen, C.L.; Cook, E.F.; Hammermeister, K.E.; Grover, F.; Daley, J. 1997: Preoperative renal risk stratification Circulation 95(4): 878-884
Pedretti, R.F.E.; Sarzi Braga, S. 2005: Non-invasive sudden death risk stratification Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(3): 180-189